NVA IPOd their lithium assets quite successfully. It gave they...

First 24 Last

Share
Profile

Follow
danbradster

6,151 Posts.

1491

02/08/24

09:19

Post #: 75038814
Share

Originally posted by zlotini: ↑

Shareholders should not be left in the dark about NE. There is no reason for this. TAFTA negotiations, which some posters believe will be wrapped up soon, seemingly, have no, bearing on the way forward for NE.

A brief review of some cold hard facts is revealing. The latest update in the quarterly results elliptically says an independent updated resource estimate for NE will be disclosed in October’s annual report. There clearly is no rush to divulge the contents of the report. Moreover, there is no guidance as to the ultimate purpose of this latest undertaking, incurring yet more costs.

A lot of money already has been thrown at a fruitless (so far), costly, adventurous, project, which has also drained vital cash, while Kingsgate struggled to survive. In recent years the big global mining company Anglo American has provided credit facilities for monies owed to it for NE. No doubt, this will not have been without additional cost.

Management has tried endlessly to flog NE with no success. Moreover, what has happened to those interested buyers, flagged a couple of years or so ago? No news update.

The possibility of a deal with a reputable mining company of decent size would make much more sense, or abandoning the project altogether, than some speculative suggestions posted. Difficult to conceive that out of nowhere, a management team capable of turning NE quickly into a highly successful project, magically will drop into place to facilitate its spin off. As for seeking fresh funds to help get the project off the ground, through an IPO, just think about the uphill struggle Kingsgate faced raising finance for its comeback.

Management should come clean right now, providing clarity for news-starved shareholders - why not?

Expand

NVA IPOd their lithium assets quite successfully. It gave they funding to avoid a year of raisings, for the exploration of their gold assets.
KCN sold off their silver assets for cheap, then the new owners were listed with a much higher market cap.

KCN Price at posting: $1.45 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 67 more messages in this thread...

First 24 Last

Add KCN (ASX) to my watchlist

(20min delay)
Last $1.34		Change -0.020(1.47%)		Mkt cap ! $345.3M

Open	High	Low	Value	Volume
$1.36	$1.38	$1.33	$47.74K	35.46K

Buyers (Bids)

No.	Vol.	Price($)
3	3816	$1.34

Sellers (Offers)

Price($)	Vol.	No.
$1.35	10355	12

View Market Depth

No.	Vol.	Price($)
4	4566	1.335
1	20000	1.330
1	755	1.325
4	28538	1.320
2	23220	1.315

Price($)	Vol.	No.
1.345	10355	12
1.350	17710	4
1.355	8671	1
1.360	33423	3
1.380	22777	2

Last trade - 10.41am 04/10/2024 (20 minute delay)

KCN (ASX) Chart

NVA IPOd their lithium assets quite successfully. It gave they...

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

NVA IPOd their lithium assets quite successfully. It gave they...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News